Quantcast

Latest IBD Stories

2011-04-08 13:54:04

Causes of IBD explored including 'hygiene hypothesis' The American College of Gastroenterology published a new evidence-based systematic review on the management of Inflammatory Bowel Disease (IBD) as a supplement to The American Journal of Gastroenterology (AJG) for April 2011, a special issue entirely dedicated to IBD. This clinical monograph, based on a comprehensive meta-analysis, offers new graded recommendations on medical management of IBD, a chronic digestive disorder which includes...

2011-03-25 00:00:30

On Sunday, April 10, 2011, the Philadelphia/Delaware Valley Chapter of the Crohn's & Colitis Foundation of America (CCFA) will hold its Annual Spring IBD Education Day at Thomas Jefferson University Hospital. Philadelphia, PA (Vocus/PRWEB) March 25, 2011 On Sunday, April 10, 2011, the Philadelphia/Delaware Valley Chapter of the Crohn's & Colitis Foundation of America (CCFA) will hold its Annual Spring IBD Education Day at Thomas Jefferson University Hospital. This free program...

2011-03-23 14:55:00

In the news release, NephRx Corp. Awarded New U.S. Patent for Oral Mucositis Agent NX002, issued 23-Mar-2011 by NephRx Corporation over PR Newswire, we are advised by the company that the original version should be disregarded. The complete, corrected release follows: NephRx Corp. Awarded U.S. Patent for Use of Novel Growth Factor Peptide NX002 in Inflammatory Bowel Disease --Validates Potential Utility of NX002 as Treatment for this Common and Disabling Condition with Significant Unmet...

2011-03-16 18:33:45

Children and adolescents growing up with inflammatory bowel disease (IBD) are less fit than their peers, says a study by researchers at McMaster University and the McMaster Children's Hospital. The study, published in the Journal of Pediatrics online, shows children and youth with the most common forms of inflammatory bowel disease have aerobic fitness levels 25 per cent lower than other children their age, and their muscle function is 10 per cent lower. "Raising a child with a chronic...

2010-12-14 00:01:27

The Crohn's & Colitis Foundation was proud to honor three leaders in the field of IBD research and treatment on Friday, December 10th at its 2010 Advances in Inflammatory Bowel Diseases Clinical & Research Conference (http://www.AdvancesInIBD.com) in Hollywood, Florida. New York, NY (Vocus) December 13, 2010 The Crohn's & Colitis Foundation was proud to honor three leaders in the field of IBD research and treatment on Friday, December 10th at its 2010 Advances in Inflammatory...

2010-12-09 16:43:00

SAN DIEGO, Dec. 9, 2010 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, and The Regents of the University of California, Los Angeles campus, today announced the execution of an exclusive research agreement that will focus on the identification of biological markers of mucosal healing in patients with Inflammatory Bowel Disease (IBD). The research will be led by Dr. Jonathan Braun, Chair of the Department of Pathology and Laboratory Medicine...

2010-11-30 22:13:43

Majority of infections in hospitalized patients with liver disease are health-care associated Death and length of stay are increased among hospitalized inflammatory bowel disease (IBD) patients who develop hospital-acquired infections, according to a study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute. Also, health-care-associated and hospital-acquired infections are most frequent in patients with severe liver...

2010-11-30 06:15:00

OAKLAND, Calif., Nov. 30, 2010 /PRNewswire-USNewswire/ -- The Kenneth Rainin Foundation announced today its 2011 Innovator Awards Program for Inflammatory Bowel Disease. The Program, now in its second year, is designed to accelerate the pace of discovery in IBD research. Approximately four million people worldwide suffer from some form of IBD. Although the disease can occur at any age, the peak onset is between the ages of 15 to 30. Approximately 10% of the cases occur in children,...

2010-10-27 06:30:00

MOUNTAIN VIEW, Calif., Oct. 27 /PRNewswire/ -- ChemoCentryx, Inc., today announced that it reported one-year results from the Company's PROTECT-1 Study (the Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial) of Traficet-EN(TM) (CCX282-B) in patients with moderate-to-severe Crohn's disease. Traficet-EN, an orally bioavailable CCR9-specific chemokine receptor antagonist showed clinical efficacy in a 12-week Induction period, as well as a 36-week Maintenance period....

2010-10-18 16:37:04

At the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, Texas, several studies of the effectiveness of non"X"ray techniques to evaluate Crohn's disease revealed that diagnostic strategies such as capsule endoscopy (CE) and magnetic resonance enteroscopy (MRE) are useful in managing patients with inflammatory bowel disease (IBD) and avoiding ionizing radiation. IBD Patients Exposed to Significant Ionizing Radiation...


Word of the Day
maffling
  • To stammer.
  • Present participle of maffle, to stammer.
  • A simpleton.
The word 'maffle' may come from a Dutch word meaning 'to move the jaws' or a French word meaning 'having large cheeks'.